Stage I nonsmall cell lung carcinoma: analysis of survival and implications for screening.


BACKGROUND Skepticism about the radical curability of lung carcinoma, even when diagnosed in Stage I, has been long fostered by the epidemiologists' dogma against lung cancer screening, and by official recommendations not to screen for lung carcinoma. Follow-up of patients with asymptomatic screen-detected Stage I nonsmall cell lung carcinoma (NSCLC… (More)


  • Presentations referencing similar topics